GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound momelotinib

Analyse Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7NNS
Type
protein
Length
296 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Activin receptor type I
EC
2.7.11.30
UniProt
Q04771
Ligands
C87, SO4
Pockets
3 · best druggability 0.70

Structure

x-ray diffraction · 1 distinct chain · 38% helix, 22% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
BActivin receptor type I (EC 2.7.11.30)protein29638% helix, 22% strandQ04771

Ligands and binding sites

  • C87 · Momelotinib · ligand · chains B
  • SO4 · Sulfate ion · ion · 7 copies · chains B
  • EDO · 1,2-ethanediol · additive · 6 copies · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14710.700.8049EDO, C87, SO4
21420.550.8125EDO
3660.320.7520EDO

Compared structures

  • 7NNS · Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound Momelotinib · the same entry in another collection · chain B against B, TM-score 1.00
  • Q04771 · AlphaFold monomer V2.0 prediction for activin receptor type-1 (Q04771) · a predicted model of the same protein · chain B against A, TM-score 0.96

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.